LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer | |
Fizazi, Karim; Tran, Namphuong; Fein, Luis Enrique; Matsubara, Nobuaki; Antolin, Alfredo Rodriguez; Alekseev, Boris Y.; Ozguroglu, Mustafa; Ye, Dingwei; Feyerabend, Susan; Protheroe, Andrew | |
2017 | |
卷号 | 35 |
会议录 | JOURNAL OF CLINICAL ONCOLOGY |
语种 | 英语 |
URL标识 | 查看原文 |
ISSN号 | 0732-183X |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3620774 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Fizazi, Karim,Tran, Namphuong,Fein, Luis Enrique,et al. LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer[C]. 见:. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论